In a desperate effort to stop the virus...

Biotech stocks are seeing a windfall of spending Biotech stocks are seeing a windfall of spending Outsider Club: Because You'll Never Be on the Inside... [Outsider Club logo] In a desperate effort to stop the virus... By Dave Roberts | October 20, 2021 - Baltimore, MD The federal government has just authorized over $227 billion in urgent medical spending. A huge portion of this money will flow into a surprisingly small number of biotech companies... And this massive cash infusion should drive their stock prices THROUGH THE ROOF. If you invest in those companies now, you’ll be set up for a massive payday... And we’re just getting started! Overall, global medical spending is on track to soar past the $7 trillion mark! Never before has the entire world jammed so much money into one small market sector. This is a once-in-a-lifetime opportunity, and we don’t want you to miss out. That’s why our own Keith Kohl is releasing [this urgent presentation]( on biotech investing. In it, you’ll learn about several stocks on the verge of BIG medical breakthroughs... The data-driven way to predict whether the FDA will approve these breakthroughs... And how to time an investment to capitalize PERFECTLY on those approvals. We believe [one of these stocks]( could turn every $2,500 into $193,800. So if you want to make hundreds of thousands (if not millions!) from the red-hot biotech sector, don’t delay: [Watch Keith’s urgent presentation now!]( To your wealth, [dave-roberts-signature] Dave Roberts Vice President of Media, Topline Trader P.S. Here at Angel Publishing, we pride ourselves on being ahead of the trends. We recommended Bitcoin and cannabis LONG before anyone else, setting our readers up for gains of 2,528% and 3,015%, respectively. But this biotech explosion should be WAY bigger than that. There is over $7 trillion flowing into medical spending right now. [Find out how to get your share.]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Outsider Club, Copyright © 2021, Outsider Club LLC and Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](